These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34105505)

  • 1. [Therapeutic Effect of Convalescent Plasma Transfusion on Fulminant Viral Infectious Diseases--Review].
    Wang HR; Liu HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):988-992. PubMed ID: 34105505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China.
    Huang S; Shen C; Xia C; Huang X; Fu Y; Tian L
    Med Sci Monit; 2020 Dec; 26():e928755. PubMed ID: 33264276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan.
    Hassan MO; Osman AA; Elbasit HEA; Hassan HE; Rufai H; Satti MMM; Elnegoumi M; Idris R; Musa A; Ali AH; Zroog SA; Altayb ADA; Khairy A; Allam M; Abdelhalim ATI
    Transfus Apher Sci; 2020 Dec; 59(6):102918. PubMed ID: 32900597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma.
    Vandeberg P; Cruz M; Diez JM; Merritt WK; Santos B; Trukawinski S; Wellhouse A; Jose M; Willis T
    Transfusion; 2021 Jun; 61(6):1705-1709. PubMed ID: 33715160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia.
    Figlerowicz M; Mania A; Lubarski K; Lewandowska Z; Służewski W; Derwich K; Wachowiak J; Mazur-Melewska K
    Transfus Apher Sci; 2020 Oct; 59(5):102866. PubMed ID: 32636116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients.
    Farag YMK
    Mayo Clin Proc; 2020 Dec; 95(12):2801-2802. PubMed ID: 33276848
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with convalescent plasma for COVID-19 patients in Wuhan, China.
    Ye M; Fu D; Ren Y; Wang F; Wang D; Zhang F; Xia X; Lv T
    J Med Virol; 2020 Oct; 92(10):1890-1901. PubMed ID: 32293713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of transfusion convalescent recovery plasma in patients with coronavirus disease 2019.
    Xiao K; Lin Y; Fan Z; Wen Y; Huang H; Wang M; Ren D; Wu C; Liu W; Zhang Z; Li G; LE A
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):565-570. PubMed ID: 32879108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Reply - Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients.
    Joyner MJ; Senefeld JW; Klassen SA; Fairweather D; Wright RS; Carter RE
    Mayo Clin Proc; 2020 Dec; 95(12):2802-2803. PubMed ID: 33276849
    [No Abstract]   [Full Text] [Related]  

  • 12. Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies.
    Li Y; Liu S; Zhang S; Ju Q; Zhang S; Yang Y; Wang H
    Transfus Apher Sci; 2020 Oct; 59(5):102839. PubMed ID: 32561113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.
    Li L; Zhang W; Hu Y; Tong X; Zheng S; Yang J; Kong Y; Ren L; Wei Q; Mei H; Hu C; Tao C; Yang R; Wang J; Yu Y; Guo Y; Wu X; Xu Z; Zeng L; Xiong N; Chen L; Wang J; Man N; Liu Y; Xu H; Deng E; Zhang X; Li C; Wang C; Su S; Zhang L; Wang J; Wu Y; Liu Z
    JAMA; 2020 Aug; 324(5):460-470. PubMed ID: 32492084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
    Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
    Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.
    Nomoto H; Kutsuna S; Okuma K; Kuramitsu M; Tezuka K; Ikebe E; Saito S; Kinoshita N; Terada M; Endo M; Suzuki T; Miyazato Y; Nakamoto T; Inada M; Hamaguchi I; Ohmagari N
    J Infect Chemother; 2021 Apr; 27(4):653-655. PubMed ID: 33487533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of convalescent plasma for treatment of coronavirus disease 2019 patients].
    Chen S; Lu C; Li P; Wang L; Wang H; Yang Q; Chen-Li Y; Li J; Ma H; Sang Q; Xu L; Li J; Zhang Y; Kang Y; Xing L; Zhang G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1293-1298. PubMed ID: 33463485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma.
    Kong Y; Cai C; Ling L; Zeng L; Wu M; Wu Y; Zhang W; Liu Z
    Transfus Apher Sci; 2020 Oct; 59(5):102820. PubMed ID: 32467007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of Convalescent Plasma Transfusion.
    Franchini M; Glingani C
    Mayo Clin Proc; 2021 May; 96(5):1368-1369. PubMed ID: 33958067
    [No Abstract]   [Full Text] [Related]  

  • 19. The Successful Recovery of a Critically Ill COVID-19 Patient, Following the Combination of Therapeutic Plasma Exchange and Convalescent Plasma Transfusion: A Case Report.
    Novacescu AN; Duma G; Sandesc D; Sorescu T; Licker M
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection.
    Hosseini P; Rahimi H; Najafabadi MM; Ghorbani A; Najafabadi SK; Faridzadeh A; Arabpour J; Khormali E; Deravi N
    Acta Med Indones; 2021 Jan; 53(1):86-95. PubMed ID: 33818411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.